Business Courier: Band Connect selected for prestigious program
Venture Lab-backed startup reaches pre-seed fundraising goal
A University of Cincinnati Venture Lab-backed startup has reached its pre-seed fundraising goal and been accepted into one of the world’s top accelerator programs, the Cincinnati Business Courier reported.
The startup, Band Connect, has created technology that allows an in-clinic experience for physical therapy patients at home while providing clinicians insight into their patients’ form and progress.
It was one of 12 companies selected for the Techstars Healthcare Accelerator's three-month cohort held in Los Angeles. The accelerator will offer exposure to industry-specific partners.
“They are payors and providers, and we need both of those in order for the solution to work,” Band Connect co-founder and CEO Abby McInturf, a 2018 UC alumna, told the Business Courier. “We feel like they can best help us catalyze the momentum we have right now.”
With $120,000 in equity financing from Techstars Healthcare as part of the accelerator, Band Connect has completed its $500,000 pre-seed funding round.
Band Connect likely will raise a $2.5 million to $3 million seed round later this year to fund a targeted clinical and commercial launch. The accelerator should help with that as its companies typically go on to raise more than $2 million of outside capital after the program, per the accelerator.
Featured image at top: Abby McInturf, Band Connect’s co-founder. Photo by Gregory Glevicky/UC Office of Innovation
About UC Venture Lab
A leading model for urban-centered universities, the UC Venture Lab activates a high density of rapidly curated startup opportunities that attract outside entrepreneurial talent and investors. We connect university students, faculty, staff, and alumni to talent and funding to help launch new companies. Our team includes Office of Innovation staff as well as Entrepreneurs-in-Residence (EIRs), coaches, curated service providers, and subject matter experts.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.